Treatments for Blocked Carotid Arteries Vary by U.S. Region
CHICAGO, July 26, 2010 —Medicare beneficiaries in some parts of the United States appear more likely to receive carotid endarterectomy, a surgical procedure to clear blockages in the artery supplying blood to the head, whereas those in other regions more often receive stents for the same condition, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"Carotid endarterectomy has been the recommended treatment for patients with extracranial carotid artery disease since the publication of several randomized studies in the 1990s comparing carotid endarterectomy with medical therapy," the authors write as background information in the article. With the recent development of stents and other devices that prevent blood clots during procedures on arteries, several randomized trials have compared stents to endarterectomy in patients with carotid artery disease and had mixed results regarding heart attack, stroke and death.
A 2004 national coverage decision supported the use of carotid artery stents for Medicare beneficiaries with symptomatic disease and at high risk for surgery or participating in a clinical trial. To identify patterns in the use of stents or endarterectomy since this decision, Manesh R. Patel, M.D., of Duke University School of Medicine, Durham, N.C., and colleagues analyzed claims of patients age 65 and older from the Centers for Medicare & Medicaid Services from Jan. 1, 2003, through Dec. 31, 2006.
During this time period, nationwide rates of carotid endarterectomy among Medicare beneficiaries decreased from 3.2 per 1,000 patients per year to 2.6 per 1,000 patients per year. The claims codes for stenting first appeared in the data in 2005; 0.3 procedures were performed per 1,000 patients that year, and 0.4 per 1,000 patients received stents in 2006.
After adjusting for demographic and clinical characteristics, a significant geographic variation was found in the odds of revascularization. The New England, Mountain (Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah and Wyoming) and Pacific (Alaska, California, Hawaii, Oregon and Washington) regions tended to have the lowest rates of both procedures, whereas the East South Central (Alabama, Kentucky, Mississippi and Tennessee), East North Central (Illinois, Indiana, Michigan, Ohio and Wisconsin) and West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota) regions had the highest rates. There was nearly a nine-fold difference between the highest and lowest rate of endarterectomy across regions in 2003 and 2004 and a seven-fold difference in 2005 and 2006.
In 2005, 1.2 percent of patients had died 30 days after endarterectomy and 6.8 percent had died after one year. This compares with death rates of 2.3 percent after 30 days and 10.3 percent after one year for carotid stenting.
"Significant geographic variation was seen in the use of carotid
endarterectomy and carotid stenting among Medicare beneficiaries
and variation in the carotid imaging modalities used before
revascularization," the authors write. "Moreover, men and patients
with a prior diagnosis of peripheral vascular disease were more
likely to undergo carotid revascularization, and patients with a
prior diagnosis of coronary artery disease or a prior carotid
endarterectomy were more likely to undergo carotid stenting. These
findings suggest that the development of consensus regarding
clinical criteria for carotid imaging, such as a national standard
for appropriate use criteria, is required."
(Arch Intern Med. 2010;170:1218-1225. Available to the media pre-embargo at www.jamamedia.org)
Editor's Note: This project was funded under a contract from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions About Effectiveness Program. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
For more information, contact JAMA/Archives media relations at 312/464-JAMA (5262) or e-mail email@example.com.
Posted: July 2010